Skip to main content
DR REDDYS LABORATORIES LTD logo

DR REDDYS LABORATORIES LTD — Investor Relations & Filings

Ticker · RDY ISIN · US2561352038 LEI · 335800OVDPY3DVZR2798 BSE.NS Manufacturing
Open in API
Filings indexed 2,323 across all filing types
Latest filing 2024-09-21 Share Issue/Capital Cha…
Country IN India
Listing BSE.NS RDY

About DR REDDYS LABORATORIES LTD

https://www.drreddys.com/

Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company focused on providing affordable and innovative medicines. The company's core activities include the development, manufacturing, and marketing of a broad portfolio of products. This portfolio encompasses Active Pharmaceutical Ingredients (APIs), generic and branded-generic formulations, over-the-counter (OTC) products, and biologics. In addition to its significant presence in the generics market, the company invests in the research and development of novel molecules and proprietary products, with a focus on therapeutic areas such as dermatology and neurology. Dr. Reddy's is also committed to sustainable operations, actively working to reduce its environmental footprint through initiatives in water conservation, waste reduction, and decarbonisation.

Recent filings

Filing Released Lang Actions
Allotment of shares on exercise of Employee Stock Options
Share Issue/Capital Change Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding the allotment of equity shares upon exercise of stock options under the company's ESOP schemes. It includes detailed information about the number of shares allotted, the schemes under which they were issued, exercise prices, and other regulatory details as required under SEBI regulations. The document is short (4277 characters) and serves as an announcement of a share allotment event rather than a financial report or detailed analysis. It does not contain financial statements or management discussion but focuses on share capital changes due to stock option exercises. Therefore, it fits the category of Share Issue/Capital Change (SHA).
2024-09-21 English
FORM 6-K
Regulatory Filings
2024-09-20 English
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a short notification addressed to stock exchanges regarding the completion of a routine FDA inspection with zero observations. It is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which typically covers material events or information disclosures. The document does not contain financial data, audit results, management discussion, or any detailed report. It is an announcement of a regulatory event rather than a report or detailed filing. Given its brief nature and content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-09-20 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the publication of a newspaper notice about the loss of share certificates by shareholders. It includes a detailed notice listing lost share certificates and cautions the public against dealing with them. The document also contains other unrelated news and notices, but the primary focus is on the official notice of loss of share certificates. This type of document is an official announcement related to share certificates and shareholder information, not a financial report, earnings release, or management discussion. It is not a report itself but an announcement for public and regulatory record. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2024-09-17 English
FORM 6-K
Regulatory Filings
2024-09-16 English
Schedule of Analyst / Institutional Investor Meeting
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the schedule of analyst and institutional investor meetings. It is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. There is no financial data, no detailed report, no voting results, no management discussion, or any other detailed corporate filing content. The document is essentially a regulatory announcement about upcoming investor meetings. Given the short length (1177 characters) and the nature of the content, it is not a report or detailed presentation but a regulatory filing informing the stock exchanges and public about scheduled meetings. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2024-09-16 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.